Literature DB >> 2150638

Double-blind multicentre isradipine dose-confirmation study in Pakistan.

S M Rab1, M A Mirza, M H Khan, A Samad, M Ahmed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2150638     DOI： 10.2165/00003495-199000402-00009

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.

Authors: 
Journal:  Am J Med       Date:  1989-04-17       Impact factor: 4.965

2.  Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.

Authors:  K Simonsen; C D Sundstedt
Journal:  Am J Med       Date:  1989-04-17       Impact factor: 4.965
  2 in total
  1 in total

Review 1.  Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.